ADYNOVATE

takeda canada inc🇨🇦 Health Canada

Approval Id: 8c3dd928eb20f7bb
Drug Approval Canada Name: ADYNOVATE
Product Name: ADYNOVATE
Status: Marketed
Status Date: 2021-08-13
Original Market Date: 2021-08-13
Din: 02498588
Drug Class: Human
Dosage Form: Powder For Solution , Kit
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD02 COAGULATION FACTOR VIII
Atc Name: b 02 bd 02
Aig Number: 0158550003
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED

1000 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8c3dd928eb20f7bb

Type

Standard